{"entity":{"type":"insider","cik":"0001454396","url":"/insider/0001454396","json_url":"/insider/0001454396.json","name":"David Itamar","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":3,"n_filings":2,"first":"2010-08-18","last":"2010-11-05","span_basis":"filed_date"},"name_variants":[{"name":"David Itamar","source":"filing","n_filings":2,"first_seen":"2010-08-18","last_seen":"2010-11-05"}],"transactions":[{"id":7191596,"accession":"0001165527-10-000824","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001165527-10-000824","line_url":"/filing/0001165527-10-000824#line-1","is_derivative":false,"issuer_cik":"0001424860","issuer_name":"Enox Biopharma Inc","issuer_ticker":"NA","issuer_name_source":null,"issuer_url":"/issuer/0001424860","owner_cik":"0001454396","owner_name":"David Itamar","owner_url":"/insider/0001454396","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":201122.0,"shares_display":"201,122","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":60336.6,"total_display":"60,336.60","shares_owned_after":324361.0,"shares_owned_after_display":"324,361","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-11-04","filed_date":"2010-11-05","scope":"insider"},{"id":7257446,"accession":"0001165527-10-000600","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001165527-10-000600","line_url":"/filing/0001165527-10-000600#line-2","is_derivative":false,"issuer_cik":"0001424860","issuer_name":"Enox Biopharma Inc","issuer_ticker":"NA","issuer_name_source":null,"issuer_url":"/issuer/0001424860","owner_cik":"0001454396","owner_name":"David Itamar","owner_url":"/insider/0001454396","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":25000.0,"shares_display":"25,000","price_per_share":2.0,"price_display":"2.00","price_state":"stated","total_value":50000.0,"total_display":"50,000.00","shares_owned_after":525483.0,"shares_owned_after_display":"525,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-08-12","filed_date":"2010-08-18","scope":"insider"},{"id":7257443,"accession":"0001165527-10-000600","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001165527-10-000600","line_url":"/filing/0001165527-10-000600#line-1","is_derivative":false,"issuer_cik":"0001424860","issuer_name":"Enox Biopharma Inc","issuer_ticker":"NA","issuer_name_source":null,"issuer_url":"/issuer/0001424860","owner_cik":"0001454396","owner_name":"David Itamar","owner_url":"/insider/0001454396","role":"Officer (Chief Financial Officer)","officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":201122.0,"shares_display":"201,122","price_per_share":0.3,"price_display":"0.30","price_state":"stated","total_value":60336.6,"total_display":"60,336.60","shares_owned_after":500483.0,"shares_owned_after_display":"500,483","ownership_form":"D","is_10b5_1":null,"transaction_date":"2010-07-15","filed_date":"2010-08-18","scope":"insider"}],"next_cursor":null,"ledger_fault":false,"count":{"value":3,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":3,"open_market":true},{"code":"S","label":"Open-market sale","n":0,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":3},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001424860","name":"Enox Biopharma Inc","url":"/issuer/0001424860","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2010-08-18","last_seen":"2010-11-05"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001454396","retrieved_at":"2026-08-21T20:29:32+00:00","coverage":{"filings":1505395,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-20","last_ingest":"2026-08-21T05:23:33.898496+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}